Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dl 3-117
2. Dl 3117
3. Dl-3-117
4. Iotrol
5. Isovist
6. Isovist 300
7. Osmovist
1. Iotrol
2. 79770-24-4
3. Isovist
4. Osmovist
5. Isovist 300
6. Dl-3117
7. Compound Zk 39482
8. Zk 39 482
9. 1,3-benzenedicarboxamide, 5,5'-((1,3-dioxo-1,3-propanediyl)bis(methylimino))bis(n,n'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodo-
10. Iotrovist
11. 16fl47b687
12. 2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-n-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-n,3-n-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
13. 5,5'-(malonylbis(methylimino))bis(n,n'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodoisophthalamide)
14. Zk-39482
15. Zk-39-482
16. Iotrolanum [latin]
17. Osmovist 190
18. Osmovist 240
19. Iotrolanum
20. Iotrolum
21. Iotrolum [inn-latin]
22. Dl 3-117
23. Sh 437
24. Zk 39482
25. Unii-16fl47b687
26. Iotrolan(isovist)
27. Iotrolan [usan:inn:ban:jan]
28. Iotrolan [usan]
29. Iotrolan [inn]
30. Iotrolan [jan]
31. Iotrolan [mi]
32. Iotrolan [vandf]
33. Isovist 300 (tn)
34. Iotrolan [mart.]
35. Iotrolan [who-dd]
36. Schembl25535
37. Iotrolan (jan/usan/inn)
38. Iotrolan [orange Book]
39. Iotrolan For System Suitability
40. Iotrolan [ep Monograph]
41. Chembl1200555
42. Dtxsid0023165
43. Chebi:31715
44. Sh-l-437d
45. Db09487
46. Ft-0754152
47. D01714
48. 770i244
49. Q6064149
50. 5,5'-[(1,3-dioxopropane-1,3-diyl)bis(methylimino)]bis{n,n'-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodobenzene-1,3-dicarboxamide}
| Molecular Weight | 1626.2 g/mol |
|---|---|
| Molecular Formula | C37H48I6N6O18 |
| XLogP3 | -4.2 |
| Hydrogen Bond Donor Count | 16 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 24 |
| Exact Mass | 1625.7293 g/mol |
| Monoisotopic Mass | 1625.7293 g/mol |
| Topological Polar Surface Area | 400 Ų |
| Heavy Atom Count | 67 |
| Formal Charge | 0 |
| Complexity | 1450 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 8 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media
V08AB06 - Iotrolan
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Iotrolan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iotrolan, including repackagers and relabelers. The FDA regulates Iotrolan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iotrolan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Iotrolan supplier is an individual or a company that provides Iotrolan active pharmaceutical ingredient (API) or Iotrolan finished formulations upon request. The Iotrolan suppliers may include Iotrolan API manufacturers, exporters, distributors and traders.
click here to find a list of Iotrolan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Iotrolan DMF (Drug Master File) is a document detailing the whole manufacturing process of Iotrolan active pharmaceutical ingredient (API) in detail. Different forms of Iotrolan DMFs exist exist since differing nations have different regulations, such as Iotrolan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Iotrolan DMF submitted to regulatory agencies in the US is known as a USDMF. Iotrolan USDMF includes data on Iotrolan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Iotrolan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Iotrolan suppliers with USDMF on PharmaCompass.
Iotrolan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iotrolan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iotrolan GMP manufacturer or Iotrolan GMP API supplier for your needs.
A Iotrolan CoA (Certificate of Analysis) is a formal document that attests to Iotrolan's compliance with Iotrolan specifications and serves as a tool for batch-level quality control.
Iotrolan CoA mostly includes findings from lab analyses of a specific batch. For each Iotrolan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iotrolan may be tested according to a variety of international standards, such as European Pharmacopoeia (Iotrolan EP), Iotrolan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iotrolan USP).
LOOKING FOR A SUPPLIER?
